You are here

  • Home
  • Archive
  • Volume 10, Issue 10
  • Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants

Citation Tools

Article menu

Download PDFPDF

XML
Respiratory medicine
Protocol
Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lowe J, Gillespie D, Hubbard M, et al
Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants
BMJ Open 2020;10:e041528. doi: 10.1136/bmjopen-2020-041528